Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Hypertens Res. 2023 May;46(5):1132-1144. doi: 10.1038/s41440-023-01170-9. Epub 2023 Feb 8.
Primary aldosteronism is the most frequent secondary hypertensive disease and is characterized by an elevated risk for cardiovascular disease. The current standard treatments are adrenalectomy and/or administration of mineralocorticoid receptor blockers, both of which are effective at ameliorating hypertension via intervention for hyperaldosteronism. However, both of these approaches have side effects and contraindications, and mineralocorticoid receptor blockers also have limited preventive efficacy against cardiovascular events. Recently, in vitro experiments have shown that aldosterone regulation is closely related to abdominal fat accumulation and that there is crosstalk between aldosterone and visceral fat tissue accumulation. We previously reported that this interaction was clinically significant in renal dysfunction; however, its effects on the heart remain unclear. Here, we analyzed data from 49 patients with primary aldosteronism and 29 patients with essential hypertension to examine the potential effect of the interaction between the ratio of visceral-to-subcutaneous fat tissue volume and the plasma aldosterone concentration on echocardiographic indices, including the tissue Doppler-derived E/e' ratio. A significant interaction was found in patients with primary aldosteronism (p < 0.05), indicating that patients with the combination of a high plasma aldosterone concentration and high visceral-to-subcutaneous fat ratio show an increased E/e' ratio, which is a well-known risk factor for future cardiovascular events. Our results confirm the clinical importance of the interaction between aldosterone and abdominal fat tissue, suggesting that an improvement in the visceral-to-subcutaneous fat ratio may be synergistically and complementarily effective in reducing the elevated risk of cardiovascular disease in patients with primary aldosteronism when combined with conventional therapies for reducing aldosterone activity. A significant effect of the interaction between plasma aldosterone concentration and the visceral-to-subcutaneous fat ratio on the tissue Doppler-derived E/e' ratio in patients with primary aldosteronism.
原发性醛固酮增多症是最常见的继发性高血压病,其特征是心血管疾病风险增加。目前的标准治疗方法是肾上腺切除术和/或盐皮质激素受体阻滞剂的应用,这两种方法都通过干预醛固酮过多症有效改善高血压。然而,这两种方法都有副作用和禁忌症,而且盐皮质激素受体阻滞剂对心血管事件的预防效果也有限。最近,体外实验表明,醛固酮的调节与腹部脂肪堆积密切相关,醛固酮与内脏脂肪组织堆积之间存在相互作用。我们之前报道过这种相互作用在肾功能障碍中具有临床意义;然而,其对心脏的影响尚不清楚。在这里,我们分析了 49 例原发性醛固酮增多症患者和 29 例原发性高血压患者的数据,以研究内脏脂肪与皮下脂肪组织体积比与血浆醛固酮浓度之间相互作用对超声心动图指标的潜在影响,包括组织多普勒衍生的 E/e'比值。在原发性醛固酮增多症患者中发现了显著的相互作用(p<0.05),表明血浆醛固酮浓度高且内脏脂肪与皮下脂肪比值高的患者 E/e'比值增加,E/e'比值是未来心血管事件的一个已知危险因素。我们的结果证实了醛固酮与腹部脂肪组织之间相互作用的临床重要性,表明改善内脏脂肪与皮下脂肪比值可能与降低醛固酮活性的常规治疗相结合,对降低原发性醛固酮增多症患者心血管疾病风险的升高具有协同和互补作用。